Cognition and Aging Well with Migraine

You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!

Key Questions
  • How does migraine change over time?
  • As people age and approach their 60s and 70s, can the headache part of a migraine attack start to lessen and other symptoms become more bothersome?
  • How does chronic migraine evolve over time?
  • Is there hope for people with chronic migraine?
  • What causes late onset migraine?
  • How does treatment differ for late onset migraine?
  • Is it possible to take triptans over the age of 65?
  • Does migraine have a cumulative effect or damage over time?
  • Should we be worried about white matter lesions in an MRI scan?
  • What are some concerns about taking migraine medications long term?
  • Does migraine confer any risk of dementia, stroke, or heart disease?
  • Is there hope for people who have migraine at an older age?
Interview Notes
Shivang Joshi

Shivang Joshi, MD, MPH, RPh

Associate Professor of Clinical Pharmacy Practice and Headache Specialist
University of Buffalo School of Pharmacy, DENT Neurological Institute

Dr. Shivang Joshi is a doctor, pharmacist, and migraine and pharmacology expert. He is board-certified in neurology and headache medicine. Dr. Joshi is also an associate professor of clinical pharmacy practice at the University at Buffalo School of Pharmacy. He is an award-winning researcher and teacher. He is a recipient of the American Headache Society’s 2012 “Frontiers in Headache Research” Scholarship Award for Cluster Headache Research, and the “Outstanding Teaching Award” from the Albert Einstein College of Medicine. He has recently joined DENT Neurologic Institute, where he treats existing and new patients.

Purchase full access to the entire 2024 Summit to unlock:

  • All expert interviews with separate audio (MP3) files & transcripts
  • 30 extended, uncut interview editions with hours more expert footage
  • Lifetime on-demand access with no annual fee to 2024 Summit
  • Interview Summaries
  • Treatment Directory & Guidelines
  • And much more!
Order your 2024 Access Pass

Related Talks for: Day 8 (2020) Taking Control

Migraine and Psychological Comorbidities

Paul R. Martin, PhD

Navigating Insurance and Access Issues

Katie Golden

Migraine at Work: Issues and Progress

Elena Ruiz de la Torre


Brian Grosberg, MD

The European Migraine & Headache Alliance is a non-profit umbrella organization, that includes over 30 patient associations for Migraine, Cluster Headache, Trigeminal Neuralgia and other headache diseases, across Europe.

Learn more

View more/less

VYEPTI is a new treatment for the challenges 
 you—or someone you know—may face with 
 this condition.

Learn more

View more/less

There are now over 300 items listed in this updated directory of treatments, therapies, devices, procedures, strategies and approaches to treat or prevent migraine. Only available with 2020 VIP Access Pass.

View more/less

Leave a comment

Back to top